Hepatocellular Carcinoma Clinical Trials in Regensburg
3 recruitingRegensburg, Germany
Showing 1–3 of 3 trials
Recruiting
Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
AstraZeneca1,220 enrolled204 locationsNCT06921785
Recruiting
Phase 2
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
ImmunotherapyHCC - Hepatocellular Carcinoma
Michael Dill48 enrolled7 locationsNCT05690048
Recruiting
Phase 2
Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab
Hepatocellular Carcinoma Non-resectable
Ludwig-Maximilians - University of Munich106 enrolled7 locationsNCT04224636